Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Demel, Cornelia ^a   Hoegen, Tobias ^a   Giese, Armin ^b   Angele, Barbara ^a   Pfister, Hans Walter ^a   Koedel, Uwe ^a   Klein, Matthias ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CEFTRIAXONE; DEXAMETHASONE; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR P75; PLACEBO; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; NERVE GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDIOMETRY; BRAIN CORTEX; CELL DENSITY; CELL LOSS; COCHLEA; CONTROLLED STUDY; DRUG EFFICACY; HEARING LOSS; HIPPOCAMPUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; MOUSE; NERVE CELL; NONHUMAN; PNEUMOCOCCAL MENINGITIS; SPIRAL GANGLION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; ASTROCYTE; BACTERIAL MENINGITIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEFTRIAXONE; CEREBRAL CORTEX; COCHLEA; DEXAMETHASONE; DISEASE MODELS, ANIMAL; HEARING LOSS; HIPPOCAMPUS; HUMANS; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, INBRED C57BL; NEURONS; NEUROTROPHIN 3; PLACEBOS; RECEPTORS, NERVE GROWTH FACTOR; SPIRAL GANGLION;

EID: 78751646035     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-7     Document Type: Article

References (57)

1. Koedel U. Toll-like receptors in bacterial meningitis. Curr Top Microbiol Immunol 2009, 336:15-40. full_text, 19688326.
2. Klein M, Koedel U, Kastenbauer S, Pfister HW. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Infection 2008, 36:2-14. 10.1007/s15010-007-7153-1, 18084715.
3. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moisi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009, 7:47. 10.1186/1741-7015-7-47, 2759956, 19751516.
4. Klein M, Schmidt C, Kastenbauer S, Paul R, Kirschning CJ, Wagner H, Popp B, Pfister HW, Koedel U. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 2007, 195:1189-1193. 10.1086/512859, 17357057.
5. Klein M, Koedel U, Pfister HW, Kastenbauer S. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 2003, 13:123-132. 10.1111/j.1750-3639.2003.tb00012.x, 12744466.
6. Merchant SN, Gopen Q. A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am J Otol 1996, 17:375-385.
7. Klein M, Koedel U, Pfister HW. Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy?. Prog Neurobiol 2006, 80:269-280. 10.1016/j.pneurobio.2006.11.008, 17215069.
8. Weber JR, Tuomanen EI. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol 2007, 184:45-52. 10.1016/j.jneuroim.2006.11.016, 17210186.
9. van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 9:254-263. 10.1016/S1474-4422(10)70023-5, 20138011.
10. Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998, 44:592-600. 10.1002/ana.410440404, 9778257.
11. Kastenbauer S, Klein M, Koedel U, Pfister HW. Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res 2001, 904:208-217. 10.1016/S0006-8993(01)02164-3, 11406118.
12. Winter AJ, Marwick S, Osborne M, Comis S, Stephen J, Tarlow M. Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs. Acta Otolaryngol 1996, 116:401-407. 10.3109/00016489609137864, 8790739.
13. Caye-Thomasen P, Worsoe L, Brandt CT, Miyazaki H, Ostergaard C, Frimodt-Moller N, Thomsen J. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope 2009, 119:1560-1570. 10.1002/lary.20260, 19504554.
14. Meli DN, Coimbra RS, Erhart DG, Loquet G, Bellac CL, Tauber MG, Neumann U, Leib SL. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 2006, 74:3890-3896. 10.1128/IAI.01949-05, 1489684, 16790761.
15. Tinling SP, Colton J, Brodie HA. Location and timing of initial osteoid deposition in postmeningitic labyrinthitis ossificans determined by multiple fluorescent labels. Laryngoscope 2004, 114:675-680. 10.1097/00005537-200404000-00015, 15064623.
16. Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, Hill J, Mitchell TJ. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 1997, 65:4411-4418. 175634, 9353013.
17. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997, 15:631-643. 10.1016/S0736-5748(96)00117-7, 9263039.
18. Nadol JB, Young YS, Glynn RJ. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1989, 98:411-416.
19. Lyxell B, Andersson J, Andersson U, Arlinger S, Bredberg G, Harder H. Phonological representation and speech understanding with cochlear implants in deafened adults. Scand J Psychol 1998, 39:175-179. 10.1111/1467-9450.393075, 9800533.
20. Pisoni DB, Geers AE. Working memory in deaf children with cochlear implants: correlations between digit span and measures of spoken language processing. Ann Otol Rhinol Laryngol Suppl 2000, 185:92-93.
21. Yukawa K, Cohen L, Blamey P, Pyman B, Tungvachirakul V, O'Leary S. Effects of insertion depth of cochlear implant electrodes upon speech perception. Audiol Neurootol 2004, 9:163-172. 10.1159/000077267, 15084821.
22. Fayad JN, Linthicum FH. Multichannel cochlear implants: relation of histopathology to performance. Laryngoscope 2006, 116:1310-1320. 10.1097/01.mlg.0000227176.09500.28, 16885730.
23. Nadol JB, Hsu WC. Histopathologic correlation of spiral ganglion cell count and new bone formation in the cochlea following meningogenic labyrinthitis and deafness. Ann Otol Rhinol Laryngol 1991, 100:712-716.
24. Nadol JB. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation. Otolaryngol Head Neck Surg 1997, 117:220-228. 10.1016/S0194-5998(97)70178-5, 9334769.
25. Fritzsch B, Tessarollo L, Coppola E, Reichardt LF. Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance. Prog Brain Res 2004, 146:265-278. full_text, 14699969.
26. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996, 19:289-317. 10.1146/annurev.ne.19.030196.001445, 8833445.
27. Wise AK, Hume CR, Flynn BO, Jeelall YS, Suhr CL, Sgro BE, O'Leary SJ, Shepherd RK, Richardson RT. Effects of Localized Neurotrophin Gene Expression on Spiral Ganglion Neuron Resprouting in the Deafened Cochlea. Mol Ther 2010, 18(6):1111-22. 10.1038/mt.2010.28, 20216530.
28. Ernfors P, Van De Water T, Loring J, Jaenisch R. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995, 14:1153-1164. 10.1016/0896-6273(95)90263-5, 7605630.
29. Altschuler RA, Cho Y, Ylikoski J, Pirvola U, Magal E, Miller JM. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci 1999, 884:305-311. 10.1111/j.1749-6632.1999.tb08650.x, 10842602.
30. Ernfors P, Duan ML, ElShamy WM, Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 1996, 2:463-467. 10.1038/nm0496-463, 8597959.
31. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996, 7:889-894. 10.1097/00001756-199603220-00011, 8724667.
32. Richardson RT, Wise AK, Thompson BC, Flynn BO, Atkinson PJ, Fretwell NJ, Fallon JB, Wallace GG, Shepherd RK, Clark GM, O'Leary SJ. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009, 30:2614-2624. 10.1016/j.biomaterials.2009.01.015, 19178943.
33. Shepherd RK, Coco A, Epp SB. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res 2008, 242:100-109. 10.1016/j.heares.2007.12.005, 2630855, 18243608.
34. Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, Steiner I. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008, 15:649-659. 10.1111/j.1468-1331.2008.02193.x, 18582342.
35. Kim HH, Addison J, Suh E, Trune DR, Richter CP. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study. Laryngoscope 2007, 117:1209-1215. 10.1097/MLG.0b013e318058195f, 17603319.
36. Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol 2003, 54:451-458. 10.1002/ana.10684, 14520656.
37. Noben-Trauth K, Zheng QY, Johnson KR. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 2003, 35:21-23. 10.1038/ng1226, 2864026, 12910270.
38. Johnson KR, Zheng QY, Noben-Trauth K. Strain background effects and genetic modifiers of hearing in mice. Brain Res 2006, 1091:79-88. 10.1016/j.brainres.2006.02.021, 2858224, 16579977.
39. Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J Infect Dis 2000, 182:1437-1445. 10.1086/315877, 11023466.
40. Kuo LT, Simpson A, Schanzer A, Tse J, An SF, Scaravilli F, Groves MJ. Effects of systemically administered NT-3 on sensory neuron loss and nestin expression following axotomy. J Comp Neurol 2005, 482:320-332. 10.1002/cne.20400, 15669078.
41. Alcala-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH, McLoon LK. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 2010, 18:179-190. 10.3109/10611860903318134, 19807216.
42. Pettingill LN, Minter RL, Shepherd RK. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 2008, 152:821-828. 10.1016/j.neuroscience.2007.11.057, 2726277, 18304740.
43. Terayama Y, Kaneko K, Tanaka K, Kawamoto K. Ultrastructural changes of the nerve elements following disruption of the organ of Corti. II. Nerve elements outside the organ of Corti. Acta Otolaryngol 1979, 88:27-36. 10.3109/00016487909137136, 474117.
44. McGuinness SL, Shepherd RK. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol Neurotol 2005, 26:1064-1072. 10.1097/01.mao.0000185063.20081.50, 1851892, 16151360.
45. Dicou E, Masson C, Jabbour W, Nerriere V. Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. Neuroreport 1993, 5:321-324. 10.1097/00001756-199312000-00036, 7507728.
46. Bonini S, Lambiase A, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996, 93:10955-10960. 10.1073/pnas.93.20.10955, 38265, 8855290.
47. Azar ST, Major SC, Safieh-Garabedian B. Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. Brain Behav Immun 1999, 13:361-366. 10.1006/brbi.1999.0554, 10600222.
48. Quarcoo D, Fischer TC, Peckenschneider N, Groneberg DA, Welker P. High abundances of neurotrophin 3 in atopic dermatitis mast cell. J Occup Med Toxicol 2009, 4:8. 10.1186/1745-6673-4-8, 2680865, 19386090.
49. Gadient RA, Cron KC, Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990, 117:335-340. 10.1016/0304-3940(90)90687-5, 2094822.
50. Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M, Loo C, Garcia C, Sloane DL, Rosenthal A, Lin JC. TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology 2008, 149:1038-1048. 10.1210/en.2007-1166, 18063676.
51. Apfel SC. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol 1999, 9:393-413. 10.1111/j.1750-3639.1999.tb00234.x, 10219753.
52. Sahenk Z, Nagaraja HN, McCracken BS, King WM, Freimer ML, Cedarbaum JM, Mendell JR. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology 2005, 65:681-689. 10.1212/01.WNL.0000171978.70849.c5, 16157899.
53. Klein M, Paul R, Angele B, Popp B, Pfister HW, Koedel U. Protein expression pattern in experimental pneumococcal meningitis. Microbes Infect 2006, 8:974-983. 10.1016/j.micinf.2005.10.013, 16488173.
54. Nau R, Gerber J, Bunkowski S, Bruck W. Axonal injury, a neglected cause of CNS damage in bacterial meningitis. Neurology 2004, 62:509-511.
55. Kesser BW, Hashisaki GT, Spindel JH, Ruth RA, Scheld WM. Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg 1999, 120:628-637. 10.1053/hn.1999.v120.a92772, 10229585.
56. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284. 10.1086/425368, 15494903.
57. van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010, 9:254-263. 10.1016/S1474-4422(10)70023-5, 2835871, 20138011.